Epirubicin loaded to pre-polymerized poly(butyl cyanoacrylate) nanoparticles: Preparation and in vitro evaluation in human lung adenocarcinoma cells

被引:26
|
作者
Yordanov, Georgi [1 ]
Evangelatov, Alexander [2 ]
Skrobanska, Ralica [2 ]
机构
[1] Sofia Univ St Kliment Ohridski, Fac Chem & Pharm, Sofia 1164, Bulgaria
[2] Sofia Univ St Kliment Ohridski, Fac Biol, Sofia 1164, Bulgaria
关键词
Epirubicin; Poly(butyl cyanoacrylate); Nanoparticles; Lung cancer; A549; Cytotoxicity; Drug uptake; SOLID LIPID NANOPARTICLES; PHASE-II TRIAL; MACROMOLECULAR THERAPEUTICS; 1ST-LINE CHEMOTHERAPY; TARGETED DELIVERY; DOSE EPIRUBICIN; DOXORUBICIN; CANCER; DRUG; TUMOR;
D O I
10.1016/j.colsurfb.2013.02.002
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
This article describes the preparation of epirubicin-loaded nanoparticles, prepared by loading of the drug in pre-polymerized poly(butyl cyanoacrylate) nanoparticles, their physicochemical characterization and in vitro evaluation on human lung adenocarcinoma (A549) cells. Nanoparticles were also coated in aqueous dispersions with two different non-ionic surfactants (Pluronic F68 and Polysorbate 80). All particles were spherical in shape, with monomodal size distributions. The zeta-potentials at pH 7.4 increased with augmentation of the particle drug content. The increased drug content was found to correlate with the initial concentration of the drug, used for the particle preparation. In vitro studies on A549 cells showed that the drug-loaded nanoparticles, as well as the combinations of free drug and empty nanoparticles, exhibited higher cytotoxicity than the free drug alone. The presence of surfactants also resulted in increased cytotoxicity. Fluorescent imaging of epirubicin internalization by the adenocarcinoma cells revealed that the free drug was predominantly localized in the cell nucleus, while a cytoplasmic localization was observed for the nanoparticle-bound drug formulations, suggesting the probability of nanoparticle endocytosis. Thus the hereby presented results could be useful for development of nanoparticle-based anthracycline formulations for treatment of lung adenocarcinoma. (C) 2013 Elsevier B.V. All rights reserved.
引用
收藏
页码:115 / 123
页数:9
相关论文
共 50 条
  • [21] In vitro toxicity of serum protein-adsorbed citrate-reduced gold nanoparticles in human lung adenocarcinoma cells
    Choi, Seon Young
    Jeong, Saeromi
    Jang, Soo Hwa
    Park, Jin
    Park, Jin Ho
    Ock, Kwang Su
    Lee, So Yeong
    Joo, Sang-Woo
    TOXICOLOGY IN VITRO, 2012, 26 (02) : 229 - 237
  • [22] In vitro evaluation of antitumoral efficacy of catalase in combination with traditional chemotherapeutic drugs against human lung adenocarcinoma cells
    de Oliveira, Valeska Aguiar
    da Motta, Leonardo Lisboa
    De Bastiani, Marco Antonio
    Lopes, Fernanda Martins
    Muller, Carolina Beatriz
    Gabiatti, Bernardo Papini
    Franca, Fernanda Stapenhorst
    Alves Castro, Mauro Antonio
    Klamt, Fabio
    TUMOR BIOLOGY, 2016, 37 (08) : 10775 - 10784
  • [23] Evaluation of in vitro cytotoxicity and genotoxicity of copper-zinc alloy nanoparticles in human lung epithelial cells
    Kumbicak, Umit
    Cavas, Tolga
    Cinkilic, Nilufer
    Kumbicak, Zubeyde
    Vatan, Ozgur
    Yilmaz, Dilek
    FOOD AND CHEMICAL TOXICOLOGY, 2014, 73 : 105 - 112
  • [24] Enhancing the efficiency of bortezomib conjugated to pegylated gold nanoparticles: an in vitro study on human pancreatic cancer cells and adenocarcinoma human lung alveolar basal epithelial cells
    Coelho, Slvia Castro
    Almeida, Gabriela M.
    Santos-Silva, Filipe
    Pereira, Maria Carmo
    Coelho, Manuel A. N.
    Expert Opinion on Drug Delivery, 2016, 13 (08) : 1075 - 1081
  • [25] Investigation of in vitro biological activities of hollow mesoporous carbon nanoparticles bearing D-NMAPPD on human lung adenocarcinoma cells
    Ugur, Naz
    Harputlu, Ersan
    Sezer, Canan Vejselova
    Demirdogen, Ruken Esra
    Ince, Mine
    Unlu, C. Gokhan
    Yurt, Fatma
    Emen, Fatih Mehmet
    Kutlu, Hatice Mehtap
    Ocakoglu, Kasim
    JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY, 2022, 67
  • [26] In vitro anti-cancer activity of a polyherbal preparation, VEDICINALS®9, against A549 human lung adenocarcinoma cells
    Paudel, Keshav Raj
    Rajput, Rashi
    De Rubis, Gabriele
    Allam, Venkata Sita Rama Raju
    Williams, Kylie Anne
    Singh, Sachin Kumar
    Gupta, Gaurav
    Salunke, Prakash
    Hansbro, Philip Michael
    Gerlach, Joachim
    Dua, Kamal
    PATHOLOGY RESEARCH AND PRACTICE, 2023, 250
  • [27] Paclitaxel-loaded poly(D,L-lactide-co-glycolide) nanoparticles for radiotherapy in hypoxic human tumor cells in vitro
    Jin, Cheng
    Bai, Ling
    Wu, Hong
    Liu, Junye
    Guo, Guozhen
    Chen, Jingyuan
    CANCER BIOLOGY & THERAPY, 2008, 7 (06) : 911 - 916
  • [28] Cisplatin Loaded Poly(L-glutamic acid)-g-Methoxy Poly(ethylene glycol) Complex Nanoparticles for Potential Cancer Therapy: Preparation, In Vitro and In Vivo Evaluation
    Yu, Haiyang
    Tang, Zhaohui
    Li, Mingqiang
    Song, Wantong
    Zhang, Dawei
    Zhang, Ying
    Yang, Yan
    Sun, Hai
    Deng, Mingxiao
    Chen, Xuesi
    JOURNAL OF BIOMEDICAL NANOTECHNOLOGY, 2016, 12 (01) : 69 - 78
  • [29] Erlotinib-Loaded Poly(ε-Caprolactone) Nanocapsules Improve In Vitro Cytotoxicity and Anticlonogenic Effects on Human A549 Lung Cancer Cells
    Franciele Aline Bruinsmann
    Julieti Huch Buss
    Gabriele Dadalt Souto
    Eduarda Schultze
    Aline de Cristo Soares Alves
    Fabiana Kömmling Seixas
    Tiago Veiras Collares
    Adriana Raffin Pohlmann
    Silvia Stanisçuaski Guterres
    AAPS PharmSciTech, 21
  • [30] Synthesis, characterization and in vitro anti-cancer evaluation of hesperetin-loaded nanoparticles in human oral carcinoma (KB) cells
    Gurushankar, K.
    Gohulkumar, M.
    Prasad, N. Rajendra
    Krishnakumar, N.
    ADVANCES IN NATURAL SCIENCES-NANOSCIENCE AND NANOTECHNOLOGY, 2014, 5 (01)